Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.

2.50
Hdl Handle:
http://hdl.handle.net/10147/254134
Title:
Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.
Authors:
Sherlock, M; Fernandez-Rodriguez, E; Alonso, A Aragon; Reulen, R C; Ayuk, J; Clayton, R N; Holder, G; Sheppard, M C; Bates, A; Stewart, P M
Affiliation:
Division of MedicalSciences, Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom.
Citation:
Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues. 2009, 94 (4):1255-63 J. Clin. Endocrinol. Metab.
Publisher:
The Journal of clinical endocrinology and metabolism
Journal:
The Journal of clinical endocrinology and metabolism
Issue Date:
Apr-2009
URI:
http://hdl.handle.net/10147/254134
DOI:
10.1210/jc.2008-1420
PubMed ID:
19158203
Abstract:
Acromegaly is associated with increased morbidity and mortality. Treatment options include surgery, radiotherapy, and medical therapy.
Item Type:
Article
Language:
en
MeSH:
Acromegaly; Dopamine Agonists; Follicle Stimulating Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Luteinizing Hormone; Prolactin; Somatostatin
ISSN:
1945-7197

Full metadata record

DC FieldValue Language
dc.contributor.authorSherlock, Men_GB
dc.contributor.authorFernandez-Rodriguez, Een_GB
dc.contributor.authorAlonso, A Aragonen_GB
dc.contributor.authorReulen, R Cen_GB
dc.contributor.authorAyuk, Jen_GB
dc.contributor.authorClayton, R Nen_GB
dc.contributor.authorHolder, Gen_GB
dc.contributor.authorSheppard, M Cen_GB
dc.contributor.authorBates, Aen_GB
dc.contributor.authorStewart, P Men_GB
dc.date.accessioned2012-11-30T16:41:31Z-
dc.date.available2012-11-30T16:41:31Z-
dc.date.issued2009-04-
dc.identifier.citationMedical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues. 2009, 94 (4):1255-63 J. Clin. Endocrinol. Metab.en_GB
dc.identifier.issn1945-7197-
dc.identifier.pmid19158203-
dc.identifier.doi10.1210/jc.2008-1420-
dc.identifier.urihttp://hdl.handle.net/10147/254134-
dc.description.abstractAcromegaly is associated with increased morbidity and mortality. Treatment options include surgery, radiotherapy, and medical therapy.en_GB
dc.language.isoenen
dc.publisherThe Journal of clinical endocrinology and metabolismen_GB
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen_GB
dc.subject.meshAcromegaly-
dc.subject.meshDopamine Agonists-
dc.subject.meshFollicle Stimulating Hormone-
dc.subject.meshHuman Growth Hormone-
dc.subject.meshHumans-
dc.subject.meshInsulin-Like Growth Factor I-
dc.subject.meshLuteinizing Hormone-
dc.subject.meshProlactin-
dc.subject.meshSomatostatin-
dc.titleMedical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.en_GB
dc.typeArticleen
dc.contributor.departmentDivision of MedicalSciences, Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom.en_GB
dc.identifier.journalThe Journal of clinical endocrinology and metabolismen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus,the Irish health repository are protected by copyright, with all rights reserved, unless otherwise indicated.